Hospital Universitario de la Princesa -ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2020

  1. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162

2019

  1. Influence of a Serratia marcescens outbreak on the gut microbiota establishment process in low-weight preterm neonates

    PLoS ONE, Vol. 14, Núm. 5

2018

  1. Microbiota and Human Health: characterization techniques and transference

    Enfermedades Infecciosas y Microbiologia Clinica

2017

  1. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341

  2. Individual patterns of complexity in cystic fibrosis lung microbiota, including predator bacteria, over a 1-year period

    mBio, Vol. 8, Núm. 5

2016

  1. Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study

    Journal of Cystic Fibrosis, Vol. 15, Núm. 3, pp. 357-365

  2. Emergence of cfr-mediated linezolid resistance in a methicillin-resistant Staphylococcus aureus epidemic clone isolated from patients with cystic fibrosis

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 3, pp. 1878-1882

2014

  1. Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: Towards standard of care practices

    BMC Microbiology, Vol. 14, Núm. 1

2012

  1. Tratamiento de mantenimiento con ampicilina inhalada en pacientes con fibrosis quística e infección pulmonar por Staphylococcus aureus sensible a meticilina

    Archivos de Bronconeumologia